Advances in proton therapy in lung cancer
Lung cancer remains the leading cause of cancer deaths in the United States (US) and worldwide. Radiation therapy is a mainstay in the treatment of locally advanced non-small cell lung cancer (NSCLC) and serves as an excellent alternative for early stage patients who are medically inoperable or who...
Main Authors: | Melissa A.L. Vyfhuis, Nasarachi Onyeuku, Tejan Diwanji, Sina Mossahebi, Neha P. Amin, Shahed N. Badiyan, Pranshu Mohindra, Charles B. Simone |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-07-01
|
Series: | Therapeutic Advances in Respiratory Disease |
Online Access: | https://doi.org/10.1177/1753466618783878 |
Similar Items
-
Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer
by: Melissa A.L. Vyfhuis, MD PhD, et al.
Published: (2017-07-01) -
Role of Tissue Microenvironment in Recruiting Macrophages During Apoptosis-induced Proliferation
by: Diwanji, Neha
Published: (2020) -
Basement membrane damage by ROS- and JNK-mediated Mmp2 activation drives macrophage recruitment to overgrown tissue
by: Neha Diwanji, et al.
Published: (2020-07-01) -
Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults
by: Diwanji TP, et al.
Published: (2017-09-01) -
Scanned Proton Beam Performance and Calibration of the Shanghai Advanced Proton Therapy Facility
by: Hang Shu, et al.
Published: (2019-01-01)